- Home
- APLS vs IFS Comparison
APLS vs IFS Comparison
Compare APLS & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- IFS
- Stock Information
- Founded
- APLS 2009
- IFS 1897
- Country
- APLS United States
- IFS Peru
- Employees
- APLS N/A
- IFS N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- IFS Commercial Banks
- Sector
- APLS Health Care
- IFS Finance
- Exchange
- APLS Nasdaq
- IFS Nasdaq
- Market Cap
- APLS 3.3B
- IFS 3.3B
- IPO Year
- APLS 2017
- IFS 2019
- Fundamental
- Price
- APLS $24.27
- IFS $33.50
- Analyst Decision
- APLS Buy
- IFS Buy
- Analyst Count
- APLS 18
- IFS 1
- Target Price
- APLS $45.53
- IFS $30.00
- AVG Volume (30 Days)
- APLS 1.7M
- IFS 170.5K
- Earning Date
- APLS 05-06-2025
- IFS 05-12-2025
- Dividend Yield
- APLS N/A
- IFS 2.85%
- EPS Growth
- APLS N/A
- IFS 21.96
- EPS
- APLS N/A
- IFS 3.02
- Revenue
- APLS $781,367,000.00
- IFS $1,189,396,011.00
- Revenue This Year
- APLS $12.95
- IFS N/A
- Revenue Next Year
- APLS $21.35
- IFS $9.67
- P/E Ratio
- APLS N/A
- IFS $10.98
- Revenue Growth
- APLS 97.02
- IFS 9.69
- 52 Week Low
- APLS $23.25
- IFS $20.56
- 52 Week High
- APLS $59.91
- IFS $34.60
- Technical
- Relative Strength Index (RSI)
- APLS 40.15
- IFS 57.34
- Support Level
- APLS $23.25
- IFS $33.46
- Resistance Level
- APLS $24.88
- IFS $34.53
- Average True Range (ATR)
- APLS 0.91
- IFS 0.78
- MACD
- APLS 0.11
- IFS -0.01
- Stochastic Oscillator
- APLS 38.35
- IFS 68.57
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of financial services through banking, insurance, and wealth management businesses, as well as the recent integration of Izipay enhancing its payments ecosystem. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services, and Payments segment provides administration services, operation and processing of credit and debit cards. Its geographical segments include Peru and Panama.